nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—metabolic syndrome X	0.897	1	CbGaD
Nepafenac—PTGS2—Nicotinamide salvaging—NAMPT—metabolic syndrome X	0.00586	0.0829	CbGpPWpGaD
Nepafenac—PTGS1—artery—metabolic syndrome X	0.00325	0.137	CbGeAlD
Nepafenac—PTGS2—Nicotinate metabolism—NAMPT—metabolic syndrome X	0.00312	0.0441	CbGpPWpGaD
Nepafenac—PTGS2—artery—metabolic syndrome X	0.0031	0.131	CbGeAlD
Nepafenac—PTGS1—endothelium—metabolic syndrome X	0.00274	0.116	CbGeAlD
Nepafenac—PTGS2—endothelium—metabolic syndrome X	0.00262	0.111	CbGeAlD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—HSD11B1—metabolic syndrome X	0.00259	0.0366	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PLA2G6—metabolic syndrome X	0.00255	0.0361	CbGpPWpGaD
Nepafenac—PTGS1—blood vessel—metabolic syndrome X	0.00253	0.107	CbGeAlD
Nepafenac—PTGS2—blood vessel—metabolic syndrome X	0.00242	0.102	CbGeAlD
Nepafenac—PTGS1—Arachidonic acid metabolism—EPHX2—metabolic syndrome X	0.00227	0.0321	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—FGF21—metabolic syndrome X	0.00216	0.0306	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—HSD11B1—metabolic syndrome X	0.00206	0.0291	CbGpPWpGaD
Nepafenac—PTGS2—Eicosanoid Synthesis—PLA2G6—metabolic syndrome X	0.00203	0.0286	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—EPHX2—metabolic syndrome X	0.0018	0.0255	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.00179	0.0253	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—GGT1—metabolic syndrome X	0.00158	0.0223	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—CRP—metabolic syndrome X	0.00132	0.0186	CbGpPWpGaD
Nepafenac—PTGS2—Eicosanoid Synthesis—GGT1—metabolic syndrome X	0.00125	0.0177	CbGpPWpGaD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—metabolic syndrome X	0.00113	0.016	CbGpPWpGaD
Nepafenac—PTGS1—cardiovascular system—metabolic syndrome X	0.00113	0.0477	CbGeAlD
Nepafenac—PTGS1—kidney—metabolic syndrome X	0.0011	0.0467	CbGeAlD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—metabolic syndrome X	0.00109	0.0154	CbGpPWpGaD
Nepafenac—PTGS2—cardiovascular system—metabolic syndrome X	0.00108	0.0456	CbGeAlD
Nepafenac—PTGS2—kidney—metabolic syndrome X	0.00106	0.0446	CbGeAlD
Nepafenac—PTGS2—Overview of nanoparticle effects—CRP—metabolic syndrome X	0.00105	0.0148	CbGpPWpGaD
Nepafenac—PTGS1—adipose tissue—metabolic syndrome X	0.000995	0.0421	CbGeAlD
Nepafenac—Ketorolac—PTGS2—metabolic syndrome X	0.000963	0.114	CrCbGaD
Nepafenac—PTGS2—adipose tissue—metabolic syndrome X	0.000951	0.0402	CbGeAlD
Nepafenac—PTGS1—Biological oxidations—FMO3—metabolic syndrome X	0.000949	0.0134	CbGpPWpGaD
Nepafenac—Bromfenac—PTGS2—metabolic syndrome X	0.000923	0.109	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTGS2—metabolic syndrome X	0.000884	0.0125	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—GGT1—metabolic syndrome X	0.000876	0.0124	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—metabolic syndrome X	0.000864	0.0122	CbGpPWpGaD
Nepafenac—Tiaprofenic acid—PTGS2—metabolic syndrome X	0.000785	0.0931	CrCbGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—metabolic syndrome X	0.000764	0.0108	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGS2—metabolic syndrome X	0.000734	0.0104	CbGpPWpGaD
Nepafenac—Magnesium salicylate—PTGS2—metabolic syndrome X	0.000729	0.0865	CrCbGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	0.000723	0.0102	CbGpPWpGaD
Nepafenac—Fenbufen—PTGS2—metabolic syndrome X	0.000714	0.0847	CrCbGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—GGT1—metabolic syndrome X	0.000696	0.00983	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—SCARB1—metabolic syndrome X	0.000684	0.00967	CbGpPWpGaD
Nepafenac—PTGS2—liver—metabolic syndrome X	0.000667	0.0282	CbGeAlD
Nepafenac—Magnesium salicylate—ALB—metabolic syndrome X	0.00065	0.0771	CrCbGaD
Nepafenac—Salsalate—PTGS2—metabolic syndrome X	0.00062	0.0736	CrCbGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—metabolic syndrome X	0.000614	0.00867	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—LPL—metabolic syndrome X	0.000603	0.00852	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—TNF—metabolic syndrome X	0.000597	0.00844	CbGpPWpGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—metabolic syndrome X	0.000597	0.00844	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ABCA1—metabolic syndrome X	0.000576	0.00814	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	0.000574	0.00812	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—CD36—metabolic syndrome X	0.000573	0.00809	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—PLA2G6—metabolic syndrome X	0.000567	0.00801	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—GGT1—metabolic syndrome X	0.000558	0.00788	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SCARB1—metabolic syndrome X	0.000543	0.00767	CbGpPWpGaD
Nepafenac—Fenoprofen—PTGS2—metabolic syndrome X	0.000513	0.0608	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—IL6—metabolic syndrome X	0.000482	0.00681	CbGpPWpGaD
Nepafenac—Mefenamic acid—PTGS2—metabolic syndrome X	0.000475	0.0564	CrCbGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—TNF—metabolic syndrome X	0.000474	0.0067	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—APOB—metabolic syndrome X	0.000473	0.00669	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ABCA1—metabolic syndrome X	0.000457	0.00646	CbGpPWpGaD
Nepafenac—Fenoprofen—ALB—metabolic syndrome X	0.000457	0.0542	CrCbGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—GGT1—metabolic syndrome X	0.000443	0.00626	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—metabolic syndrome X	0.000412	0.00582	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.000408	0.00576	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CRP—metabolic syndrome X	0.000387	0.00547	CbGpPWpGaD
Nepafenac—Oxcarbazepine—ALB—metabolic syndrome X	0.000383	0.0454	CrCbGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—IL6—metabolic syndrome X	0.000382	0.00541	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—APOB—metabolic syndrome X	0.000376	0.00531	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—APOA1—metabolic syndrome X	0.000374	0.00529	CbGpPWpGaD
Nepafenac—Diclofenac—PTGS2—metabolic syndrome X	0.000342	0.0405	CrCbGaD
Nepafenac—PTGS1—Biological oxidations—GGT1—metabolic syndrome X	0.000326	0.00461	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000325	0.00459	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—INS—metabolic syndrome X	0.000323	0.00457	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CCL2—metabolic syndrome X	0.000318	0.0045	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CRP—metabolic syndrome X	0.000307	0.00434	CbGpPWpGaD
Nepafenac—Diclofenac—ALB—metabolic syndrome X	0.000304	0.0361	CrCbGaD
Nepafenac—Ketoprofen—PTGS2—metabolic syndrome X	0.000303	0.0359	CrCbGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—APOA1—metabolic syndrome X	0.000297	0.0042	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—SERPINE1—metabolic syndrome X	0.000297	0.0042	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALB—metabolic syndrome X	0.000297	0.00419	CbGpPWpGaD
Nepafenac—Ketoprofen—ALB—metabolic syndrome X	0.00027	0.032	CrCbGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.00026	0.00367	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—metabolic syndrome X	0.000259	0.00367	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000258	0.00365	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—INS—metabolic syndrome X	0.000257	0.00363	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CCL2—metabolic syndrome X	0.000253	0.00357	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000246	0.00348	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—LEP—metabolic syndrome X	0.000238	0.00336	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SERPINE1—metabolic syndrome X	0.000236	0.00333	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALB—metabolic syndrome X	0.000235	0.00333	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—metabolic syndrome X	0.000234	0.0033	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—metabolic syndrome X	0.000219	0.00309	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000214	0.00303	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.000209	0.00296	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.000206	0.00291	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.000205	0.0029	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000203	0.00287	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000201	0.00284	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CCL2—metabolic syndrome X	0.0002	0.00282	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.000197	0.00278	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000195	0.00276	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000187	0.00264	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—metabolic syndrome X	0.000175	0.00248	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.00017	0.0024	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000166	0.00235	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.000166	0.00235	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000165	0.00234	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FMO3—metabolic syndrome X	0.000162	0.00229	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000161	0.00227	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.00016	0.00227	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000159	0.00225	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000154	0.00217	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000149	0.00211	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000148	0.00209	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000145	0.00205	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MLXIPL—metabolic syndrome X	0.000145	0.00204	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—EPHX2—metabolic syndrome X	0.000145	0.00204	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—metabolic syndrome X	0.000141	0.002	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—metabolic syndrome X	0.000139	0.00197	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—G6PC2—metabolic syndrome X	0.000136	0.00192	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.000134	0.00189	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000132	0.00187	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000131	0.00185	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000129	0.00183	CbGpPWpGaD
Nepafenac—PTGS2—Disease—G6PC2—metabolic syndrome X	0.000129	0.00182	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FMO3—metabolic syndrome X	0.000129	0.00182	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000127	0.0018	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000125	0.00177	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000122	0.00172	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000118	0.00167	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TGFB1—metabolic syndrome X	0.000118	0.00166	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FABP4—metabolic syndrome X	0.000116	0.00163	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000115	0.00163	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MLXIPL—metabolic syndrome X	0.000115	0.00162	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—EPHX2—metabolic syndrome X	0.000115	0.00162	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—metabolic syndrome X	0.000112	0.00159	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—metabolic syndrome X	0.00011	0.00155	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HSD11B1—metabolic syndrome X	0.00011	0.00155	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—G6PC2—metabolic syndrome X	0.000108	0.00153	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000106	0.0015	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000103	0.00146	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000103	0.00145	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000101	0.00143	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	9.94e-05	0.00141	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—G6PD—metabolic syndrome X	9.77e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	9.64e-05	0.00136	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HDAC3—metabolic syndrome X	9.54e-05	0.00135	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GCKR—metabolic syndrome X	9.32e-05	0.00132	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPA—metabolic syndrome X	9.32e-05	0.00132	CbGpPWpGaD
Nepafenac—PTGS2—Disease—G6PD—metabolic syndrome X	9.26e-05	0.00131	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FABP4—metabolic syndrome X	9.18e-05	0.0013	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HDAC3—metabolic syndrome X	9.04e-05	0.00128	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLA2G6—metabolic syndrome X	9.03e-05	0.00128	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	8.96e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA5—metabolic syndrome X	8.94e-05	0.00126	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—metabolic syndrome X	8.87e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GCKR—metabolic syndrome X	8.84e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HSD11B1—metabolic syndrome X	8.7e-05	0.00123	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	8.68e-05	0.00123	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	8.51e-05	0.0012	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	8.44e-05	0.00119	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	8.41e-05	0.00119	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TRIB3—metabolic syndrome X	8.31e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	8.21e-05	0.00116	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	8.06e-05	0.00114	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	8.01e-05	0.00113	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TRIB3—metabolic syndrome X	7.88e-05	0.00111	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RBP4—metabolic syndrome X	7.88e-05	0.00111	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—G6PD—metabolic syndrome X	7.76e-05	0.0011	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	7.65e-05	0.00108	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HDAC3—metabolic syndrome X	7.57e-05	0.00107	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	7.48e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NAMPT—metabolic syndrome X	7.45e-05	0.00105	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	7.41e-05	0.00105	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LIPC—metabolic syndrome X	7.41e-05	0.00105	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GCK—metabolic syndrome X	7.41e-05	0.00105	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCKR—metabolic syndrome X	7.4e-05	0.00105	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPA—metabolic syndrome X	7.4e-05	0.00105	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOC3—metabolic syndrome X	7.36e-05	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLA2G6—metabolic syndrome X	7.17e-05	0.00101	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CETP—metabolic syndrome X	7.15e-05	0.00101	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	7.12e-05	0.00101	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA5—metabolic syndrome X	7.1e-05	0.001	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NAMPT—metabolic syndrome X	7.06e-05	0.000999	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GCK—metabolic syndrome X	7.02e-05	0.000992	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOC3—metabolic syndrome X	6.98e-05	0.000986	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	6.89e-05	0.000974	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SCARB1—metabolic syndrome X	6.84e-05	0.000967	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	6.75e-05	0.000955	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	6.68e-05	0.000944	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	6.66e-05	0.000942	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SREBF1—metabolic syndrome X	6.64e-05	0.000939	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TRIB3—metabolic syndrome X	6.6e-05	0.000932	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GOT2—metabolic syndrome X	6.46e-05	0.000913	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMGCR—metabolic syndrome X	6.46e-05	0.000913	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HMGA1—metabolic syndrome X	6.42e-05	0.000908	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GOT2—metabolic syndrome X	6.13e-05	0.000866	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CYBA—metabolic syndrome X	6.1e-05	0.000862	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NAMPT—metabolic syndrome X	5.92e-05	0.000836	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	5.88e-05	0.000831	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LIPC—metabolic syndrome X	5.88e-05	0.000831	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCK—metabolic syndrome X	5.88e-05	0.000831	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOC3—metabolic syndrome X	5.84e-05	0.000826	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.83e-05	0.000824	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCA1—metabolic syndrome X	5.76e-05	0.000814	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC2A4—metabolic syndrome X	5.76e-05	0.000814	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CETP—metabolic syndrome X	5.67e-05	0.000802	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GGT1—metabolic syndrome X	5.58e-05	0.000788	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GOT1—metabolic syndrome X	5.58e-05	0.000788	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	5.57e-05	0.000787	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC2A4—metabolic syndrome X	5.46e-05	0.000772	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SCARB1—metabolic syndrome X	5.43e-05	0.000768	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.29e-05	0.000748	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GOT1—metabolic syndrome X	5.29e-05	0.000747	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SREBF1—metabolic syndrome X	5.27e-05	0.000745	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMGCR—metabolic syndrome X	5.13e-05	0.000725	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GOT2—metabolic syndrome X	5.13e-05	0.000725	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOB—metabolic syndrome X	4.73e-05	0.000669	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLA2G4A—metabolic syndrome X	4.6e-05	0.000651	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCA1—metabolic syndrome X	4.57e-05	0.000646	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC2A4—metabolic syndrome X	4.57e-05	0.000646	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPL—metabolic syndrome X	4.52e-05	0.000639	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOB—metabolic syndrome X	4.49e-05	0.000634	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GOT1—metabolic syndrome X	4.43e-05	0.000626	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GGT1—metabolic syndrome X	4.43e-05	0.000626	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CD36—metabolic syndrome X	4.29e-05	0.000607	CbGpPWpGaD
Nepafenac—PTGS2—Disease—LPL—metabolic syndrome X	4.28e-05	0.000606	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARA—metabolic syndrome X	3.99e-05	0.000564	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AGT—metabolic syndrome X	3.87e-05	0.000547	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOE—metabolic syndrome X	3.79e-05	0.000535	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOB—metabolic syndrome X	3.76e-05	0.000531	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA1—metabolic syndrome X	3.74e-05	0.000529	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLA2G4A—metabolic syndrome X	3.66e-05	0.000517	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOE—metabolic syndrome X	3.59e-05	0.000508	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPL—metabolic syndrome X	3.59e-05	0.000507	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOA1—metabolic syndrome X	3.55e-05	0.000502	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CD36—metabolic syndrome X	3.41e-05	0.000482	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—metabolic syndrome X	3.3e-05	0.000466	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—INS—metabolic syndrome X	3.24e-05	0.000457	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IRS1—metabolic syndrome X	3.2e-05	0.000453	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARA—metabolic syndrome X	3.17e-05	0.000448	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AGT—metabolic syndrome X	3.07e-05	0.000434	CbGpPWpGaD
Nepafenac—PTGS2—Disease—INS—metabolic syndrome X	3.07e-05	0.000434	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOE—metabolic syndrome X	3.01e-05	0.000425	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA1—metabolic syndrome X	2.97e-05	0.00042	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—metabolic syndrome X	2.97e-05	0.000419	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—metabolic syndrome X	2.84e-05	0.000401	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—metabolic syndrome X	2.82e-05	0.000398	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—metabolic syndrome X	2.69e-05	0.00038	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—metabolic syndrome X	2.62e-05	0.00037	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—metabolic syndrome X	2.6e-05	0.000367	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—INS—metabolic syndrome X	2.57e-05	0.000363	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—metabolic syndrome X	2.36e-05	0.000333	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—metabolic syndrome X	2.25e-05	0.000318	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—metabolic syndrome X	1.78e-05	0.000251	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—metabolic syndrome X	1.34e-05	0.000189	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKT1—metabolic syndrome X	1.3e-05	0.000184	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT1—metabolic syndrome X	1.24e-05	0.000175	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKT1—metabolic syndrome X	1.04e-05	0.000146	CbGpPWpGaD
